ARTICLE

FindCenter AddIcon

Ketamine for Depression Still Too Expensive for Widespread Use

By Technology Networks — 2020

A paper authored by researchers from McLean Hospital has determined that esketamine, a nasal spray to treat severe depression, is currently too expensive for widespread use. The study compared the costs and benefits of esketamine, an antidepressant approved by the U.S. Food and Drug Administration (FDA) last year for use in treatment-resistant major depressive disorder.

Read on www.technologynetworks.com

FindCenter Post-Image

Laughter Meditation: 5 Healing Benefits and a 10-Minute Practice

In a world where there’s much to be taken seriously, it’s important to remember to laugh. Not to make light of the severity of war, discrimination, terror threats, or climate change, but to maintain a perspective that there is still much to be thankful for and to celebrate in your life.

FindCenter AddIcon

EXPLORE TOPIC

Clinical Depression